Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
Q3 2021 vs. Q2 2021
How the institutions holding Verona Pharma plc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 37 | 40 | +3 |
| Shares | 36.7M | 37.0M | +318.9K (+0.9%) |
| Value | $239.9M | $202.7M | −$37.2M (−15.5%) |
New holders (8)
Institutions that held Verona Pharma plc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 495,446 | $2.71M | 0.00% |
| Citadel Advisors LLC | 22,870 | $125.0K | 0.00% |
| Susquehanna International Group, LLP | 15,364 | $84.0K | 0.00% |
| Millennium Management LLC | 14,786 | $81.0K | 0.00% |
| Geode Capital Management, LLC | 10,707 | $58.0K | 0.00% |
| Migdal Insurance & Financial Holdings Ltd. | 1,324 | $7.00K | 0.00% |
| Plante Moran Financial Advisors, LLC | 892 | $5.00K | 0.00% |
| UBS Group AG | 879 | $5.00K | 0.00% |
Sold out (5)
Institutions that held Verona Pharma plc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Polar Capital Holdings Plc | 900,000 | $5.89M |
| Wedbush Securities Inc | 18,035 | $118.0K |
| Quantitative Systematic Strategies LLC | 14,034 | $92.0K |
| Chicago Partners Investment Group LLC | 10,006 | $58.0K |
| Endurance Wealth Management, Inc. | 2,000 | $12.0K |